Niridazole, a nitrothiazole derivative, has a wide range of antimicrobial activities against helminths, protozoa (6), and bacteria, including staphylococci, streptococci, and some aerobic gram-negative bacilli (1, 5, 6, 11) .
The chemical structure of niridazole is similar to that of metronidazole (2) . Since the latter compound is especially active against anaerobic bacteria (4, 7, 12) and against certain strains of microaerophilic Campylobacter spp. (10) , it seemed worthwhile to compare the activities of niridazole and metronidazole against selected isolates of these organisms.
Niridazole (lot no. 4407841; 100% purity and activity) was obtained from Ciba-Geigy GmbH (Wehr, Federal Republic of Germany [FRG] . The other 14 were isolated from patient stool specimens. They were biotyped as described by Skirrow and Benjamin (8) . All of these isolates were grown under microaerophilic conditions overnight at 37°C. The density of a suspension was adjusted to one-half of a McFarland no. 1 standard. After a further 1:5 dilution in Mueller-Hinton broth (Oxoid Ltd.), 0.6 RI of each suspension was transferred to a MuellerHinton agar plate supplemented with 7% sheep blood and containing the appropriate drug concentrations. The inoculated plates were incubated in a microaerophilic milieu at 37°C for 18 h.
The minimum inhibitory concentration (MIC) was taken as the lowest concentration of the antibacterial agent which did not allow visible growth.
All of the anaerobic bacterial strains were susceptible to metronidazole, with MICs falling within a rather narrow range. Their susceptibility to niridazole was distinctly greater (Table 1) . Campylobacters varied somewhat in their susceptibility to metronidazole. The MICs for 5 of 10 strains of C. jejuni and all 6 C. coli strains ranged from 2 to 4 ,ug/ml. The reference strain of C. jejuni was resistant to metronidazole (MIC, 128 ,ug/ml). Niridazole was much more active against all strains of Campylobacter than metronidazole was. However, those strains which were resistant to metronidazole were also less susceptible to niridazole than other strains (Table 1).
The above results indicate that the antibacterial activity of niridazole for anaerobic and mi- (12) .
Since serum levels of niridazole higher than the MIC values are easily achievable in humans and in animals by common therapeutic dosage (3), these in vitro results could open new perspectives for the use of this antischistosomal drug.
We appreciate the accurate technical assistance of H. Kolbow.
LITERATURE CITED
